Innoviva (INVA) Market Capitalization (2010 - 2026)
Innoviva's Market Capitalization came in at $1.65 billion for Q2 2026, up 30.3% from $1.27 billion a year earlier but down 4.1% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Market Capitalization (2010 - 2026) Analysis & Trends
For FY2025, Innoviva's Market Capitalization was $1.49 billion, up 37.2% from FY2024.
- Market Capitalization has increased in each of the last three years, with a five-year compound annual growth rate of 3.5% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $1.09 billion in FY2024 (+7.1%), $1.02 billion in FY2023 (+10.8%), $916.74 million in FY2022 (-23.6%) and $1.2 billion in FY2021 (-4.5%).
- The five-year range for quarterly Market Capitalization is $740.52 million (Q1 2023) to $1.72 billion (Q1 2026).
- Year-over-year, Market Capitalization has increased for seven consecutive quarters, with growth averaging 25.8% over the last seven quarters.
- The fastest year-over-year change in Market Capitalization over five years came in Q1 2026 (growth of 51.1%), and the weakest in Q1 2023 (a decline of 45.0%).
- Business Quant data shows INVA's Market Capitalization at $1.72 billion (Q1 2026), $1.49 billion (Q4 2025) and $1.36 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Innoviva | 1.53 Bn | -757.39 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.65 Bn |
| Mar 31, 2026 | 1.72 Bn |
| Dec 31, 2025 | 1.49 Bn |
| Sep 30, 2025 | 1.36 Bn |
| Jun 30, 2025 | 1.27 Bn |
| Mar 31, 2025 | 1.14 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 957.03 Mn |
| Dec 31, 2023 | 1.02 Bn |
| Sep 30, 2023 | 836.35 Mn |
| Jun 30, 2023 | 830.31 Mn |
| Mar 31, 2023 | 740.52 Mn |
| Dec 31, 2022 | 916.74 Mn |
| Sep 30, 2022 | 810.10 Mn |
| Jun 30, 2022 | 1.03 Bn |
| Mar 31, 2022 | 1.35 Bn |
| Dec 31, 2021 | 1.20 Bn |
| Sep 30, 2021 | 1.16 Bn |
API Access
Innoviva Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();